METHOD OF TREATING CANCER WITH MAGEA3 IMMUNOTHERAPEUTIC WITH BRAF INHIBITOR AND/OR MEK INHIBITOR

A combination of anti-neoplastic agents that provides increased activity over monotherapy, or in some cases at least an unexpected lack of negative interaction. In particular, the drug combination that includes a MAGE-A3 immunotherapeutic, in combination with a B-Raf inhibitor, particularly N-{3-[5-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GERARD, CATHERINE MARIE GHISLAINE, LEHMANN, FREDERIC FRANCOIS EUGENE, LOUAHED, JAMILA, LEBOWITZ, PETER F, LAQUERRE, SYLVIE
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!